ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

Von Eschenbach Candidacy for FDA Hampered By Three Republican Holds.

December 1, 2006

Drug Development Effort Criticized

April 18, 1975

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

DCPC Advisors Commit $32 Mil. To Chemoprevention

June 7, 1991

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011